Magnetic resonance angiography at 3.0 Tesla: Initial clinical experience

Norbert G. Campeau, John Huston, Matt A. Bernstein, Chen Lin, Gordon F. Gibbs

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Magnetic resonance (MR) angiography has undergone significant development over the past decade. It has gone from being a novelty application of MR with limited clinical use to replacing catheter angiography in some clinical applications. One of the principal limitations inherent to all MR angiographic techniques is that they remain signal limited when pushed to the limits of higher resolution and short acquisition time. Developments in magnetic gradient hardware, coil design, and pulse sequences now are well optimized for MR angiography obtained at 1.5-T main magnetic field (B-field) strength, with acquisition times and imaging matrix size near their optimal limits, respectively. Recently, the United States Food and Drug Administration (FDA) approved use of clinical magnetic resonance imaging with main magnetic field strengths of up to 4 T. Before FDA approval, use of MR with magnetic field strengths much greater than 1.5 T was essentially reserved for investigational or research applications. The main advantage of high B-field imaging is a significant improvement in the signal-to-noise ratio (SNR), which increases in an approximately linear fashion with field strength in the range of 1.5 to 3.0 T. This increased SNR is directly available when performing MR angiographic acquisitions at higher magnetic field strengths, allowing for better resolution and conspicuity of vessels with similar acquisition times. Little has been reported on the benefits of performing MR angiography at magnetic field strengths >1.5 T. The purpose of this article is to summarize our current experience with intracranial and cervical MR angiographic techniques at 3.0 T.

Original languageEnglish (US)
Pages (from-to)183-204
Number of pages22
JournalTopics in Magnetic Resonance Imaging
Volume12
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Magnetic Resonance Angiography
Magnetic Fields
Magnetic Resonance Spectroscopy
Signal-To-Noise Ratio
United States Food and Drug Administration
Drug Approval
Angiography
Catheters
Magnetic Resonance Imaging
Research

Keywords

  • 3.0 Tesla
  • Magnetic resonance angiography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Magnetic resonance angiography at 3.0 Tesla : Initial clinical experience. / Campeau, Norbert G.; Huston, John; Bernstein, Matt A.; Lin, Chen; Gibbs, Gordon F.

In: Topics in Magnetic Resonance Imaging, Vol. 12, No. 3, 2001, p. 183-204.

Research output: Contribution to journalArticle

Campeau, Norbert G. ; Huston, John ; Bernstein, Matt A. ; Lin, Chen ; Gibbs, Gordon F. / Magnetic resonance angiography at 3.0 Tesla : Initial clinical experience. In: Topics in Magnetic Resonance Imaging. 2001 ; Vol. 12, No. 3. pp. 183-204.
@article{32700134a7b0468398ddcd84d80a82f6,
title = "Magnetic resonance angiography at 3.0 Tesla: Initial clinical experience",
abstract = "Magnetic resonance (MR) angiography has undergone significant development over the past decade. It has gone from being a novelty application of MR with limited clinical use to replacing catheter angiography in some clinical applications. One of the principal limitations inherent to all MR angiographic techniques is that they remain signal limited when pushed to the limits of higher resolution and short acquisition time. Developments in magnetic gradient hardware, coil design, and pulse sequences now are well optimized for MR angiography obtained at 1.5-T main magnetic field (B-field) strength, with acquisition times and imaging matrix size near their optimal limits, respectively. Recently, the United States Food and Drug Administration (FDA) approved use of clinical magnetic resonance imaging with main magnetic field strengths of up to 4 T. Before FDA approval, use of MR with magnetic field strengths much greater than 1.5 T was essentially reserved for investigational or research applications. The main advantage of high B-field imaging is a significant improvement in the signal-to-noise ratio (SNR), which increases in an approximately linear fashion with field strength in the range of 1.5 to 3.0 T. This increased SNR is directly available when performing MR angiographic acquisitions at higher magnetic field strengths, allowing for better resolution and conspicuity of vessels with similar acquisition times. Little has been reported on the benefits of performing MR angiography at magnetic field strengths >1.5 T. The purpose of this article is to summarize our current experience with intracranial and cervical MR angiographic techniques at 3.0 T.",
keywords = "3.0 Tesla, Magnetic resonance angiography",
author = "Campeau, {Norbert G.} and John Huston and Bernstein, {Matt A.} and Chen Lin and Gibbs, {Gordon F.}",
year = "2001",
doi = "10.1097/00002142-200106000-00005",
language = "English (US)",
volume = "12",
pages = "183--204",
journal = "Topics in Magnetic Resonance Imaging",
issn = "0899-3459",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Magnetic resonance angiography at 3.0 Tesla

T2 - Initial clinical experience

AU - Campeau, Norbert G.

AU - Huston, John

AU - Bernstein, Matt A.

AU - Lin, Chen

AU - Gibbs, Gordon F.

PY - 2001

Y1 - 2001

N2 - Magnetic resonance (MR) angiography has undergone significant development over the past decade. It has gone from being a novelty application of MR with limited clinical use to replacing catheter angiography in some clinical applications. One of the principal limitations inherent to all MR angiographic techniques is that they remain signal limited when pushed to the limits of higher resolution and short acquisition time. Developments in magnetic gradient hardware, coil design, and pulse sequences now are well optimized for MR angiography obtained at 1.5-T main magnetic field (B-field) strength, with acquisition times and imaging matrix size near their optimal limits, respectively. Recently, the United States Food and Drug Administration (FDA) approved use of clinical magnetic resonance imaging with main magnetic field strengths of up to 4 T. Before FDA approval, use of MR with magnetic field strengths much greater than 1.5 T was essentially reserved for investigational or research applications. The main advantage of high B-field imaging is a significant improvement in the signal-to-noise ratio (SNR), which increases in an approximately linear fashion with field strength in the range of 1.5 to 3.0 T. This increased SNR is directly available when performing MR angiographic acquisitions at higher magnetic field strengths, allowing for better resolution and conspicuity of vessels with similar acquisition times. Little has been reported on the benefits of performing MR angiography at magnetic field strengths >1.5 T. The purpose of this article is to summarize our current experience with intracranial and cervical MR angiographic techniques at 3.0 T.

AB - Magnetic resonance (MR) angiography has undergone significant development over the past decade. It has gone from being a novelty application of MR with limited clinical use to replacing catheter angiography in some clinical applications. One of the principal limitations inherent to all MR angiographic techniques is that they remain signal limited when pushed to the limits of higher resolution and short acquisition time. Developments in magnetic gradient hardware, coil design, and pulse sequences now are well optimized for MR angiography obtained at 1.5-T main magnetic field (B-field) strength, with acquisition times and imaging matrix size near their optimal limits, respectively. Recently, the United States Food and Drug Administration (FDA) approved use of clinical magnetic resonance imaging with main magnetic field strengths of up to 4 T. Before FDA approval, use of MR with magnetic field strengths much greater than 1.5 T was essentially reserved for investigational or research applications. The main advantage of high B-field imaging is a significant improvement in the signal-to-noise ratio (SNR), which increases in an approximately linear fashion with field strength in the range of 1.5 to 3.0 T. This increased SNR is directly available when performing MR angiographic acquisitions at higher magnetic field strengths, allowing for better resolution and conspicuity of vessels with similar acquisition times. Little has been reported on the benefits of performing MR angiography at magnetic field strengths >1.5 T. The purpose of this article is to summarize our current experience with intracranial and cervical MR angiographic techniques at 3.0 T.

KW - 3.0 Tesla

KW - Magnetic resonance angiography

UR - http://www.scopus.com/inward/record.url?scp=0034972627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034972627&partnerID=8YFLogxK

U2 - 10.1097/00002142-200106000-00005

DO - 10.1097/00002142-200106000-00005

M3 - Article

C2 - 11432577

AN - SCOPUS:0034972627

VL - 12

SP - 183

EP - 204

JO - Topics in Magnetic Resonance Imaging

JF - Topics in Magnetic Resonance Imaging

SN - 0899-3459

IS - 3

ER -